JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Axon Medchem

All

Home
Products
- Shop By Category
- Featured Products
- Shop By Alphabet
  - A
  - B
  - C
  - D
  - E
  - F
  - G
  - H
  - I
  - J
  - K
  - L
  - M
  - N
  - O
  - P
  - Q
  - R
  - S
  - T
  - U
  - V
  - W
  - X
  - Y
  - Z
  - #
Support
- - Customer Support
  - Customer Services
Contact
- About Axon Medchem
- Contact Us

Home
Products
Enzymes
Lyases
Carboxykinase
PEPCK
cPEPCK inhibitor

cPEPCK inhibitor

Based on 5 publications in PubMed 9 10 5

Axon 1165

CAS [628279-07-2]

MF C25H26FN5O3
MW 463.50

Purity: 98%
Soluble in DMSO

cPEPCK inhibitor

Description

The first GTP-competitive inhibitor of human cytosolic phosphoenolpyruvate carboxykinase (PEPCK or cPEPCK) with low submicromolar IC50 values.

KEYWORDS: cPEPCK inhibitor | supplier | cPEPCK inhibitor | CAS [628279-07-2] | Gluconeogenesis | PEPCK | GTP-competitive | human | cytosolic | phosphoenolpyruvate carboxykinase | glucose homeostasis | Type 2 | diabetes

LH Foley et al. Modified 3-alkyl-1,8-dibenzylxanthines as GTP-competitive inhibitors of phosphoenolpyruvate carboxykinase. Bioorg. Med. Chem. Lett. 2003, 13(20), 3607-10.

LH Foley et al. X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines. Bioorg. Med. Chem. Lett. 2003, 13(21), 3871-4.

SL Pietranico et al. C-8 Modifications of 3-alkyl-1,8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase. Bioorg. Med. Chem. Lett. 2007, 17(14), 3835-9.

Cell Signaling & Oncology Diabetes & Metabolism Miscellaneous PEPCK EC 4.1.1.32

cPEPCK inhibitor

Chemical name

N-{4-[3-Butyl-1-(2-fluoro-benzyl)-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-ylmethyl]-phenyl}-acetamide

Parent CAS No.

[628279-07-2]

Order

Size	Unit Price	Stock
5 mg	€145.00	In Stock
25 mg	€580.00	In Stock

Need more? Bulk Inquiry

Please wait...